CPPC reimplemented best-model Challenge 2 score
Table S2 column J: author reimplementation best model, training all Screen1 data including seven former holdouts. Separate from submitted methods; exact best predictor/hyperparameters per row unextracted.
Overview
Table S2 column J: author reimplementation best model, training all Screen1 data including seven former holdouts. Separate from submitted methods; exact best predictor/hyperparameters per row unextracted.
Consult the linked sources for architecture or protocol details. Missing evidence is not evidence of a missing capability.
13 recorded evaluations, 13 metric rows. A comparison chart has not yet been validated for these results. The table retains the individual findings and their sources.
Results
Results are available, but no reviewed comparison panel is linked in this release.
All evaluations
13 evaluations · 13 results. Different protocols are not a single leaderboard.
Filter evaluations
Applied filters: All linked evaluations
| Tested configuration | Protocol and dataset | Finding | Evidence and details |
|---|---|---|---|
| Configuration: CPPC reimplemented best model row 12 (5Features) | Protocol: CPPC reimplemented best-model Challenge 2 score Dataset: CPPC B16-OVA mouse melanoma T-cell perturbation screens | 0.519 reimplemented-best-topk-overlap-auc score · higher Uncertainty: Not reported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceNot reported Aggregation: Not reported CPPC Table S2 original and reimplemented submission comparisons · Supplementary Table S2; media-3.xlsx sheet 'Challenge 1 & 2'; cell J12; raw XLSX numeric value (not rounded display) |
| Configuration: CPPC reimplemented best model row 16 (scETM) | Protocol: CPPC reimplemented best-model Challenge 2 score Dataset: CPPC B16-OVA mouse melanoma T-cell perturbation screens | 0.49 reimplemented-best-topk-overlap-auc score · higher Uncertainty: Not reported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceNot reported Aggregation: Not reported CPPC Table S2 original and reimplemented submission comparisons · Supplementary Table S2; media-3.xlsx sheet 'Challenge 1 & 2'; cell J16; raw XLSX numeric value (not rounded display) |
| Configuration: CPPC reimplemented best model row 2 (PPI_Weighted) | Protocol: CPPC reimplemented best-model Challenge 2 score Dataset: CPPC B16-OVA mouse melanoma T-cell perturbation screens | 0.531 reimplemented-best-topk-overlap-auc score · higher Uncertainty: Not reported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceNot reported Aggregation: Not reported CPPC Table S2 original and reimplemented submission comparisons · Supplementary Table S2; media-3.xlsx sheet 'Challenge 1 & 2'; cell J2; raw XLSX numeric value (not rounded display) |
| Configuration: CPPC reimplemented best model row 22 (GO-node2vec) | Protocol: CPPC reimplemented best-model Challenge 2 score Dataset: CPPC B16-OVA mouse melanoma T-cell perturbation screens | 0.544 reimplemented-best-topk-overlap-auc score · higher Uncertainty: Not reported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceNot reported Aggregation: Not reported CPPC Table S2 original and reimplemented submission comparisons · Supplementary Table S2; media-3.xlsx sheet 'Challenge 1 & 2'; cell J22; raw XLSX numeric value (not rounded display) |
| Configuration: CPPC reimplemented best model row 23 (Matrix_completion) | Protocol: CPPC reimplemented best-model Challenge 2 score Dataset: CPPC B16-OVA mouse melanoma T-cell perturbation screens | 0.586 reimplemented-best-topk-overlap-auc score · higher Uncertainty: Not reported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceNot reported Aggregation: Not reported CPPC Table S2 original and reimplemented submission comparisons · Supplementary Table S2; media-3.xlsx sheet 'Challenge 1 & 2'; cell J23; raw XLSX numeric value (not rounded display) |
| Configuration: CPPC reimplemented best model row 24 (GeneVector) | Protocol: CPPC reimplemented best-model Challenge 2 score Dataset: CPPC B16-OVA mouse melanoma T-cell perturbation screens | 0.48 reimplemented-best-topk-overlap-auc score · higher Uncertainty: Not reported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceNot reported Aggregation: Not reported CPPC Table S2 original and reimplemented submission comparisons · Supplementary Table S2; media-3.xlsx sheet 'Challenge 1 & 2'; cell J24; raw XLSX numeric value (not rounded display) |
| Configuration: CPPC reimplemented best model row 3 (GWPS_K562 (H2M)) | Protocol: CPPC reimplemented best-model Challenge 2 score Dataset: CPPC B16-OVA mouse melanoma T-cell perturbation screens | 0.629 reimplemented-best-topk-overlap-auc score · higher Uncertainty: Not reported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceNot reported Aggregation: Not reported CPPC Table S2 original and reimplemented submission comparisons · Supplementary Table S2; media-3.xlsx sheet 'Challenge 1 & 2'; cell J3; raw XLSX numeric value (not rounded display) |
| Configuration: CPPC reimplemented best model row 4 (14Features) | Protocol: CPPC reimplemented best-model Challenge 2 score Dataset: CPPC B16-OVA mouse melanoma T-cell perturbation screens | 0.538 reimplemented-best-topk-overlap-auc score · higher Uncertainty: Not reported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceNot reported Aggregation: Not reported CPPC Table S2 original and reimplemented submission comparisons · Supplementary Table S2; media-3.xlsx sheet 'Challenge 1 & 2'; cell J4; raw XLSX numeric value (not rounded display) |
| Configuration: CPPC reimplemented best model row 5 (scBERT) | Protocol: CPPC reimplemented best-model Challenge 2 score Dataset: CPPC B16-OVA mouse melanoma T-cell perturbation screens | 0.514 reimplemented-best-topk-overlap-auc score · higher Uncertainty: Not reported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceNot reported Aggregation: Not reported CPPC Table S2 original and reimplemented submission comparisons · Supplementary Table S2; media-3.xlsx sheet 'Challenge 1 & 2'; cell J5; raw XLSX numeric value (not rounded display) |
| Configuration: CPPC reimplemented best model row 6 (scVI) | Protocol: CPPC reimplemented best-model Challenge 2 score Dataset: CPPC B16-OVA mouse melanoma T-cell perturbation screens | 0.577 reimplemented-best-topk-overlap-auc score · higher Uncertainty: Not reported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceNot reported Aggregation: Not reported CPPC Table S2 original and reimplemented submission comparisons · Supplementary Table S2; media-3.xlsx sheet 'Challenge 1 & 2'; cell J6; raw XLSX numeric value (not rounded display) |
| Configuration: CPPC reimplemented best model row 7 (Expression_Conditioned) | Protocol: CPPC reimplemented best-model Challenge 2 score Dataset: CPPC B16-OVA mouse melanoma T-cell perturbation screens | 0.543 reimplemented-best-topk-overlap-auc score · higher Uncertainty: Not reported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceNot reported Aggregation: Not reported CPPC Table S2 original and reimplemented submission comparisons · Supplementary Table S2; media-3.xlsx sheet 'Challenge 1 & 2'; cell J7; raw XLSX numeric value (not rounded display) |
| Configuration: CPPC reimplemented best model row 8 (Exon) | Protocol: CPPC reimplemented best-model Challenge 2 score Dataset: CPPC B16-OVA mouse melanoma T-cell perturbation screens | 0.501 reimplemented-best-topk-overlap-auc score · higher Uncertainty: Not reported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceNot reported Aggregation: Not reported CPPC Table S2 original and reimplemented submission comparisons · Supplementary Table S2; media-3.xlsx sheet 'Challenge 1 & 2'; cell J8; raw XLSX numeric value (not rounded display) |
| Configuration: CPPC reimplemented best model row 9 (Gene2Vec) | Protocol: CPPC reimplemented best-model Challenge 2 score Dataset: CPPC B16-OVA mouse melanoma T-cell perturbation screens | 0.506 reimplemented-best-topk-overlap-auc score · higher Uncertainty: Not reported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceNot reported Aggregation: Not reported CPPC Table S2 original and reimplemented submission comparisons · Supplementary Table S2; media-3.xlsx sheet 'Challenge 1 & 2'; cell J9; raw XLSX numeric value (not rounded display) |
Source checking is not independent reproduction. Release 2026-09-30-e37e3ab1284d.
Methods and evaluation design
Procedure, tasks and evaluated configurations
Evaluation design
Benchmarks bring together tasks and protocols. A task describes the biological question; a protocol defines a particular test.
These source-backed links do not make different protocols or scores interchangeable.
Recorded evaluations
Each evaluation records what was tested and under which conditions.
Baseline coverage
Reference methods help show what a model adds beyond simple controls. We track a null control and a conventional method for each protocol.
0 of 2 active baseline roles have published Rewire measurements in this release. Measurements on a selected protocol do not establish coverage of an entire suite.
No execution recipe linked to this protocol. Recipe availability does not establish a completed evaluation.
- Author-reported evaluations
- 13
Literature evidence is not a Rewire measurement. Executed but unpublished runs and private review status are not included.
Null control
Proposed control: requires review
Select a task-valid null control after reviewing inputs and metric
Protocol-specific applicability, permitted inputs, access, split, evaluator and execution requirements need review before implementation or execution.
This is a suggested selection rule, not a validated method or a measured score.
Conventional reference
Proposed control: requires review
Select an upstream conventional reference after reviewing the full protocol
Protocol-specific applicability, permitted inputs, access, split, evaluator and execution requirements need review before implementation or execution.
This is a suggested selection rule, not a validated method or a measured score.
Protocol coverage CSV · Model evaluation matrix · Source table · Release and checksums
Coverage is derived from release 2026-09-30-e37e3ab1284d. Source citations describe the original records; they do not validate an unreviewed baseline proposal. No results have been generated by this audit.
Run instructions
No runnable recipe has been reviewed for this protocol. Dataset access, model requirements, licences and compute requirements must be checked against its sources before execution.
Strengths, limitations and unresolved questions
Evidence
Source checking verifies the cited claim or transcription. It does not establish independent reproduction.
Evidence table
Inspect claims, sources and review details
Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.
One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.
3 evidence rows matching the loaded filters
| Property and statement | Original source and location | Review and provenance |
|---|---|---|
| Relationship: part of ucc-research-benchmark-cppc Individual claims | Cancer Immunotherapy Data Science Challenge official code Challenge setup and results; Supplementary Table S2 Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: 283328a9b8afc6e882eeb503ac4710bbe9f37371 | source checked automated source review · 2026-09-30T21:43:56Z Audit detailsPrimary-source table transcription and scope review; no independent reproduction or human scientific review. Field: Claim: ucc-research-membership-cppc-challenge2-reimplemented-best Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Relationship: part of ucc-research-benchmark-cppc Individual claims | Cancer Immunotherapy Data Science Challenge Challenge setup and results; Supplementary Table S2 Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: 10.64898/2026.05.21.726863v1; 2026 preprint | source checked automated source review · 2026-09-30T21:43:56Z Audit detailsPrimary-source table transcription and scope review; no independent reproduction or human scientific review. Field: Claim: ucc-research-membership-cppc-challenge2-reimplemented-best Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Relationship: part of ucc-research-benchmark-cppc Individual claims | CPPC Table S2 original and reimplemented submission comparisons Challenge setup and results; Supplementary Table S2 Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: Table S2 media-3.xlsx, 10.64898/2026.05.21.726863v1 | source checked automated source review · 2026-09-30T21:43:56Z Audit detailsPrimary-source table transcription and scope review; no independent reproduction or human scientific review. Field: Claim: ucc-research-membership-cppc-challenge2-reimplemented-best Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record Archive member: media-3.xlsx |
Sources and history
View linked audit checks and correction history
Release 2026-09-30-e37e3ab1284d · Record review: source checked
2 source records and release history
- Cancer Immunotherapy Data Science Challenge · Original source · 10.64898/2026.05.21.726863v1; 2026 preprint
- CPPC Table S2 original and reimplemented submission comparisons · Original source · Table S2 media-3.xlsx, 10.64898/2026.05.21.726863v1
Technical metadata and extraction receipts
Stable ID: ucc-research-protocol-cppc-challenge2-reimplemented-best
- review
- method: automated_source_review; actor: Codex research coverage worker; reviewed at: 2026-09-30T21:43:56Z; note: Primary-source table transcription and scope review; no independent reproduction or human scientific review.
- selection
- post-hoc best-model column; no uncertainty printed
- metric definition
- Custom ranking AUC as reported by Table S2 best-model column; per-objective details unextracted; do not equate with original final aggregate.
Related records
- dataset: CPPC B16-OVA mouse melanoma T-cell perturbation screens
- part of: Cancer Immunotherapy Data Science Challenge
- protocol: cppc table s2 j row 12
- protocol: cppc table s2 j row 16
- protocol: cppc table s2 j row 2
- protocol: cppc table s2 j row 22
- protocol: cppc table s2 j row 23
- protocol: cppc table s2 j row 24
- protocol: cppc table s2 j row 3
- protocol: cppc table s2 j row 4
- protocol: cppc table s2 j row 5
- protocol: cppc table s2 j row 6
- protocol: cppc table s2 j row 7
- protocol: cppc table s2 j row 8
- protocol: cppc table s2 j row 9
- subject: Source membership: ucc-research-protocol-cppc-challenge2-reimplemented-best